Saito Y - Search Results

1

Reply to Accurate Risk Prediction Model for Surgical Site Infection After Lower Third Molar Surgery.

Yamagami A, Narumi K, Saito Y, Furugen A, Imai S, Kitagawa Y, Ohiro Y, Takagi R, Takekuma Y, Sugawara M, Kobayashi M. Yamagami A, et al. Among authors: saito y. Oral Dis. 2024 Nov 3. doi: 10.1111/odi.15184. Online ahead of print. Oral Dis. 2024. PMID: 39491027 No abstract available.

2

H+-dependent transport mechanism of nateglinide in the brush-border membrane of the rat intestine.

Itagaki S, Saito Y, Kubo S, Otsuka Y, Yamamoto Y, Kobayashi M, Hirano T, Iseki K. Itagaki S, et al. Among authors: saito y. J Pharmacol Exp Ther. 2005 Jan;312(1):77-82. doi: 10.1124/jpet.104.074021. Epub 2004 Aug 17. J Pharmacol Exp Ther. 2005. PMID: 15316092

3

Intestinal uptake of nateglinide by an intestinal fluorescein transporter.

Itagaki S, Otsuka Y, Kubo S, Okumura H, Saito Y, Kobayashi M, Hirano T, Iseki K. Itagaki S, et al. Among authors: saito y. Biochim Biophys Acta. 2005 Mar 1;1668(2):190-4. doi: 10.1016/j.bbamem.2004.12.005. Epub 2005 Jan 13. Biochim Biophys Acta. 2005. PMID: 15737329 Free article.

4

Substrate specificity of the nateglinide/H(+) cotransport system for phenolic acids.

Saito Y, Itagaki S, Otsuka Y, Kobayashi Y, Okumura H, Kobayashi M, Hirano T, Iseki K. Saito Y, et al. J Agric Food Chem. 2005 Jul 27;53(15):6100-4. doi: 10.1021/jf050387v. J Agric Food Chem. 2005. PMID: 16029002

5

Nateglinide uptake by a ceftibuten transporter in the rat kidney brush-border membrane.

Kobayashi M, Saito Y, Itagaki S, Hirano T, Iseki K. Kobayashi M, et al. Among authors: saito y. Biochim Biophys Acta. 2005 Aug 30;1715(1):19-24. doi: 10.1016/j.bbamem.2005.05.013. Biochim Biophys Acta. 2005. PMID: 16087153 Free article.

6

Purification by p-aminobenzoic acid (PABA)-affinity chromatography and the functional reconstitution of the nateglinide/H+ cotransport system in the rat intestinal brush-border membrane.

Saito Y, Itagaki S, Kubo S, Kobayashi M, Hirano T, Iseki K. Saito Y, et al. Biochem Biophys Res Commun. 2006 Feb 17;340(3):879-86. doi: 10.1016/j.bbrc.2005.12.092. Epub 2005 Dec 27. Biochem Biophys Res Commun. 2006. PMID: 16403453 Free article.

7

Premedication with intravenous magnesium has a protective effect against cisplatin-induced nephrotoxicity.

Saito Y, Kobayashi M, Yamada T, Kasashi K, Honma R, Takeuchi S, Shimizu Y, Kinoshita I, Dosaka-Akita H, Iseki K. Saito Y, et al. Support Care Cancer. 2017 Feb;25(2):481-487. doi: 10.1007/s00520-016-3426-5. Epub 2016 Oct 3. Support Care Cancer. 2017. PMID: 27699503

8

Magnesium attenuates cisplatin-induced nephrotoxicity by regulating the expression of renal transporters.

Saito Y, Okamoto K, Kobayashi M, Narumi K, Yamada T, Iseki K. Saito Y, et al. Eur J Pharmacol. 2017 Sep 15;811:191-198. doi: 10.1016/j.ejphar.2017.05.034. Epub 2017 May 18. Eur J Pharmacol. 2017. PMID: 28529140

9

Magnesium co-administration decreases cisplatin-induced nephrotoxicity in the multiple cisplatin administration.

Saito Y, Okamoto K, Kobayashi M, Narumi K, Furugen A, Yamada T, Iseki K. Saito Y, et al. Life Sci. 2017 Nov 15;189:18-22. doi: 10.1016/j.lfs.2017.08.028. Epub 2017 Aug 31. Life Sci. 2017. PMID: 28864226

10

[Survey of the Efficacy of Long-term and Successive Pharmaceutical Care in Outpatient Chemotherapy by Oncology Pharmacy Specialists].

Saito Y, Harada S, Kobayashi M, Ueda K, Yamazaki K, Kumai M, Miyamoto T, Kasashi K, Yamada T, Komatsu Y, Iseki K. Saito Y, et al. Yakugaku Zasshi. 2018;138(11):1409-1416. doi: 10.1248/yakushi.18-00081. Yakugaku Zasshi. 2018. PMID: 30381649 Free article. Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9,684 results

Search Page

Filters